Aurora Cannabis Looks To Raise US$125 Million Via Bought Deal
Some degree of investor demand evidently remains within the Canadian cannabis sector. Aurora Cannabis (TSX: ACB) last night announced that
Read moreSome degree of investor demand evidently remains within the Canadian cannabis sector. Aurora Cannabis (TSX: ACB) last night announced that
Read moreAurora Cannabis (TSX: ACB) reported another quarter to remember last night as it continues to slash its operations in an
Read moreWhile consolidation is occurring south of the Canadian border in the US cannabis space, it also continues up here in
Read moreOn February 10th, Aurora Cannabis (TSX: ACB) reported its fiscal second quarter 2022 results. The company announced total net revenues
Read moreAurora Cannabis (TSX: ACB) this evening reported its second quarter financial results. The firm reported effectively flat quarter over quarter
Read moreAurora Cannabis (TSX: ACB) seemingly remains focused on growing its international medical cannabis operation. The firm this morning reported it
Read moreAurora Cannabis (TSX:ACB) has reportedly entered into a licensing arrangement with 22nd Century Group (NASDAQ: XXII) and Cronos Group (TSX:
Read moreOn November 18th, Bank of America terminated coverage on Tilray Inc (TSX: TLRY) and Aurora Cannabis (TSX: ACB), citing a
Read moreOn November 9th, Aurora Cannabis (TSX: ACB) reported its fiscal first quarter financial results. The company reported total revenues of
Read moreAurora Cannabis (TSX: ACB) last night released its first quarter financial results, posting revenues of $60.1 million. The firm also
Read more